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CytokinesElevated intake of certain dietary components, such as phenolic compounds of fruits and vegetables, reduces the
risk of developing obesity and other metabolic diseases characterized by a chronic, low-grade inﬂammation.
Cambuci (Campomanesia phaea O. Berg) is a Brazilian Atlantic Coastal Forest fruit rich in phenolic compounds
including ellagitannins and proanthocyanidins that were previously shown to display anti-inﬂammatory actions.
Hereinwe investigatedwhether the administration of phenolic-rich extract from cambuci (CBC) at two different
doses protects mice from diet induced obesity, insulin resistance, and chronic peripheral inﬂammation. In order
to verify this, C57BL/6J mice fed either with a chow or a high-fat, high-sucrose (HFHS) diet were daily treated by
gavage with water or CBC (18 and 32 mg gallic acid equivalent, GAE/kg body weight) for 8 weeks and evaluated
for body mass, adiposity, glucose tolerance, and adipose tissue inﬂammation. Despite the absence of changes in
bodyweight gain and adiposity, administration of CBC at two different doses protectedmice from the disarrange-
ments in glucose homeostasis induced by HFHS feeding as evidenced by the reduced fasting glycemia and
insulinemia and improved glucose tolerance featured by CBC treated mice. Along with glucose homeostasis,
CBC administration also protectedmice from adipose tissue inﬂammation induced by HFHS feeding as evidenced
by the lower expression of proinﬂammatory cytokines tumor necrosis factor-alpha (TNF-α) and interleukin-6
(IL-6) and macrophage markers CD11b, F4/80, and CD86 in retroperitoneal adipose tissue. Furthermore, the
higher dose of CBC increased plasma HDL-cholesterol while reducing LDL-cholesterol levels. Altogether, our
ﬁndings indicate that phenolic compounds from cambuci have potentially beneﬁcial actions protecting mice
from HFHS diet-induced glucose intolerance and adipose tissue inﬂammation.
© 2015 Elsevier Ltd. All rights reserved.1. Introduction
Obesity, deﬁned as an abnormal or excessive accumulation of body
fat, is a serious health issue threatening modern society. Obesity, the
prevalence of which hasmarkedly increased in the last decades, is asso-
ciated with the development of serious chronic diseases such as cancer,
diabetes and cardiomyopathies, among others, being a leading risk
factor for deaths globally and an economic burden to society. Recent
estimation indicates that overweight and obesity (body-mass index of
25 kg/m2 or greater) affects approximately 37% of theworld population,
or 2.1 billion individuals worldwide (Ng, Fleming, Robinson, et al.,
2014). This prevalence has also increased substantially in children and
adolescents in developed and developing countries. In addition, over-
weight and obesity were estimated to cause 3.4 million deaths, in
most cases, associated with cardiovascular diseases (Lim et al., 2012).+55 11 3815 4410.Several predisposing factors have been associated with obesity such
as gender, ethnicity, socioeconomic condition, education level, and diet
and regular physical activity with interactions among these factors
(Paeratakul, Lovejoy, Ryan, & Bray, 2002). Of special interest to this
study is the ﬁnding that intake of diets rich in fruits and vegetables de-
creases the prevalence of obesity and associated diseases namely type 2
diabetes, cardiovascular diseases and cancer (Carter, Gray, Troughton,
Khunti, & Davies, 2010). Although the plausible mechanisms by which
fruits and vegetables exert those protective actions are unknown, they
may be related to natural antioxidant and anti-inﬂammatory properties
featured by the chemical components of these crops (Carter et al., 2010;
Cherniack, 2011). These components include a wide range of molecules
of different structural patterns, such as phenolic compounds, caroten-
oids, vitamins and minerals (Wang, Melnyk, Tsao, & Marcone, 2011).
Brazil is the world's third largest fruit producer and seventh produc-
er of tropical fresh fruit (FAO, 2013), among which are included a large
number of native and exotic fruit species of potential interest to the food
industry that remain underexplored. Among these are theMyrtaceae, a
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Brazilian native fruits, such as jaboticaba (Myrciaria cauliﬂora Berg),
camu-camu (Myrciaria dubiaMcVaugh), and cambuci (Campomanesia
phaea O. Berg).
Cambuci grows in Brazil's Atlantic Coastal Forest, which is the
world's richest forest in terms of biodiversity. Cambuci is unique in
the genus, featuring an ovoid-rhomboidal structure with a horizontal
ridge along with a strong sweet scent, but tasting extremely sour like
lemons. These fruits are used in various typical preparations, mainly
jams, jellies, ice-cream, and liqueurs (Kawasaki & Landrum, 1997).
Despite its consumption, limited information is available on the compo-
sition and functionality of bioactive compounds of cambuci and their
potential health beneﬁts. In a previous study evaluating ethanolic ex-
tracts of seven fruits from the Brazilian Atlantic Coastal Forest, cambuci
featured the highest concentration of phenolic compounds (Haminiuk
et al., 2011), such ﬁndings that were also observed when comparing
commercial frozen pulps (Genovese, Pinto, Gonçalves, & Lajolo, 2008).
Phenolic compounds from cambuci were also found to be potent
inhibitors of carbohydrate-hydrolyzing enzymes (α-amylase and
α-glucosidase) in in vitro enzymatic assays (Gonçalves, Lajolo, &
Genovese, 2010). The suppression of glucose absorption through the
inhibition of these enzymes may be one therapeutic approach to pre-
vent the postprandial hyperglycemia. Thus, in the present study, we
investigated whether the administration of phenolic-rich extract from
cambuci (CBC) at two different doses protects mice from diet-induced
obesity, hyperglycemia, insulin resistance and chronic peripheral
inﬂammation. For this, C57BL/6J mice fed either with a chow or a
high-fat, high-sucrose (HFHS) diet were daily treated by gavage with
water or CBC (18 and 32mggallic acid equivalent, GAE/kg bodyweight)
for 8 weeks and evaluated for body mass, adiposity, glucose tolerance,
and adipose tissue inﬂammation.
2. Materials and methods
2.1. Preparation and characterization of phenolic-rich extract from cambuci
The commercial frozen pulp of cambuci was obtained from Sítio do
Bello (Paraibuna — São Paulo, Brazil). Frozen samples were thawed at
room temperature before extraction was performed. A representative
sample equivalent to 5.0 g of dry matter was homogenized and extract-
ed in 100mL of 80% aqueousmethanol using a Turratec TE-102 (Tecnal)
at 4000 rpm for 1 min, three times with intervals of 30 s, in an ice-bath,
followed by rotation using a magnetic stirrer (200 rpm) at 5 °C for
30 min. The extract was separated by centrifuging for 30 min at
5000 g and ﬁltered through a Whatman No. 3 ﬁlter paper. The precipi-
tate was resuspended twice in the aqueous alcoholic solution for addi-
tional extraction steps and then centrifuged and ﬁltered as described
above. The pooled ﬁltrates were concentrated at 39 °C to remove
methanol on a rotary evaporator (Rotavapor R-210; Büchi, Sweden),
and 40 mL of extract was made with distilled water.
The aqueous extract was added onto a preconditioned (100 mL
of methanol, 150 mL of water) LC-18 SPE tube (10 g of LC-18 SPE,
Supelclean™ LC-18, Supelco). After washing with water, the phenolic
compoundswere elutedwith 200mLofmethanol. The eluatewas evap-
orated to dryness and the residue resuspended in 70 mL of water, for
CBC18 extract, or 35 mL of water, for CBC32 extract.
The extractwas characterized in relation to total phenolics (Singleton,
Orthofer, & Lamuela-Raventos, 1999), and proanthocyanidin contents
(Porter, Hrstich, & Chan, 1985), antioxidant capacity by the oxygen radi-
cal absorbance capacity (ORAC) assay (Dávalos, Gómez-Cordovés, &
Bartolomé, 2004), the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical-
scavenging assay (Brand-Williams, Cuvelier, & Berset, 1995), and the
ferric reducing antioxidant power (FRAP) assay (Benzie & Strain, 1996),
and pancreatic lipase inhibitory activity (Nakai et al., 2005).
The identiﬁcation and quantiﬁcation of the main ﬂavonoids and
phenolic acids in cambuci were performed as described previously(Arabbi, Genovese, & Lajolo, 2004), adding the aqueous extract onto a
preconditioned (20 mL of methanol, 60 mL of water) polyamide SC6
SPE tube (1 g, Macherey-Nagel GmbH and Co., Düren, Germany). After
washing with water, phenolic compounds were eluted with 50 mL
of methanol to elute neutral phenolics, and with 50 mL of methanol:
ammonia (99.5:0.5) to elute acidic phenolics. These two fractions were
evaporated to dryness under reduced pressure at 39 °C, redissolved
in HPLC grade methanol (1 mL) and ﬁltered through 0.22 μm PTFE
(polytetraﬂuoroethylene) ﬁlters (Millipore Ltd, Bedford, MA). Identiﬁca-
tion and quantiﬁcation were performed using a Prodigy ODS3 reversed
phase silica column (5 μm, 250 × 4.6 mm, Phenomenex Ltd, Torrance,
CA), in an analytical reversed-phase HPLC (Hewlett-Packard 1100)
system with an autosampler and a quaternary pump coupled to a
diode array detector. Total ellagic acid was determined after acid hydro-
lysis according to Pinto, Lajolo, and Genovese (2008). An aliquot of 2 mL
of extract was dried under nitrogen and 2 mL of 2 N triﬂuoroacetic
acid were added, and hydrolysis was performed at 120 °C for 90 min.
The hydrolyzed samples were evaporated to dryness under nitrogen,
redissolved in methanol and ﬁltered for HPLC analysis.
2.2. Animals and experimental design
All animal procedures performed were previously approved by the
Ethical Committee for Animal Research of the Faculty of Pharmaceutical
Science of University of São Paulo (No. CEUA/FCF/378).
Forty 8-week old male C57BL/6J mice, weighting approximately
24 g, were used in this study. The mice were matched by weight and
kept at 22 ± 1 °C and under a 12-hour light/12-hour dark cycle.
All mice were fed a low-fat chow diet (NUVILAB CR-1® Sogorb Inc.,
São Paulo — SP, Brazil) ad libitum for one week before beginning the
experiment.
The animals were randomly divided into four groups of ten mice
each, as follows: 1) The Chow group received the low-fat chow diet
and water by gavage; 2) the HFHS group received the high-fat, high-
sucrose diet and water by gavage; 3) the CBC18 group received the
high-fat, high-sucrose diet and the phenolic-rich extract from cambuci
by gavage (18 mg GAE/kg body weight); and 4) the CBC32 group re-
ceived the high-fat, high-sucrose diet and the phenolic-rich extract
from cambuci by gavage (32 mg GAE/kg body weight). The water and
extracts were administered every day for 8 weeks.
According to the manufacturer, the chow diet provided 12.5 kJ/g as
energy, of which 63% was from carbohydrate, 25% from protein, and
12% from fat. The HFHS diet provided 19.4 kJ/g, 41% of calories from
sucrose, 20% from protein, and 39% from fat, as previously described
(Lemieux, Picard, Labrie, Richard, & Deshaies, 2003). Diets and water
were available ad libitum during the experimental period of 8 weeks.
Body weight and food intake were recorded every two days, and fasting
blood glucose (6 h)wasmeasured from the caudal veinweekly through-
out the study by using Accu-Chek Performa® (Roche, Mannheim,
Germany).
After 8 weeks, mice were anesthetized with isoﬂurane, immediately
euthanized by decapitation and their trunk blood was collected and
the plasma separated by centrifugation at 3000 g for 20 min at 4 °C.
The tissues, including heart, liver, gastrocnemius muscle, and adipose
tissues (inguinal, retroperitoneal, epididymal and brown)were removed,
weighed, and immediately frozen under liquid nitrogen and stored at
−80 °C.
2.3. Glucose tolerance test (GTT)
GTT was performed on the mice at week 7 of the experiment.
The animals were fasted for 6 h and injected intraperitoneally with a
glucose solution (1 g/kg body weight) and the glucose concentration
was determined in tail blood collected at baseline (prior to injection)
and at 15, 30, 45, 60 and 90 min post-injection, using the Accu-Chek
Performa® glucometer (Roche, Mannheim, Germany). Blood samples
Table 1
Primer sequences for real-time PCR.







TNF-α, tumor necrosis factor-alpha; IL-6, interleukin-6; CD11b, integrin alpha M; F4/80
EGF-like module containing, mucin-like, hormone receptor-like sequence 1; CD86; CD86
antigen; RPL3, ribosomal protein L3.
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fugation at 3000 g for 20 min at 4 °C for insulin determination (Rat/
Mouse Insulin ELISA Kit, Millipore).
2.4. Plasma biochemical parameters
A LabMax 240® (LABTEST) clinical chemistry analyzer was used to
determine plasma concentrations of total cholesterol, HDL-cholesterol,
LDL-cholesterol and triacylglycerol. Kits were purchased from LABTEST
(Lagoa Santa, MG, Brazil) and the manufacturer's instructions were
strictly followed.
2.5. Gene expression analysis by quantitative PCR
RNA puriﬁcation, reverse transcription, and quantiﬁcation by real-
time PCR were performed as previously described (Festuccia et al.,
2008). RNA was extracted from the retroperitoneal adipose tissue (ﬁve
animals per group) using an illustra RNAspin Mini RNA Isolation Kit
(GE Healthcare, Buckinghamshire, UK) according to the manufacturer's
instructions. RNA concentrationwas determined on aNanoDrop spectro-
photometer (Thermo Scientiﬁc, Wilmington, USA). RNA samples were
stored at −80 °C until use for synthesis of cDNA and real-time PCR.
Primers used for the PCR reactions are listed in Table 1. Results were
expressed as the ratio between the expression of the target gene and
the housekeeping gene RPL3, the expression of which was not
signiﬁcantly affected by the administration of CBC.
2.6. Statistical analysis
The results are presented as mean ± SEM for groups based on nine
to ten mice in each group for body and tissue weight, fasting blood glu-
cose, blood glucose in GTT and plasma lipids. For plasma insulin andFig. 1. HPLC chromatogram of ﬂavonoid glycosides and phenolic acids extracted iquantitative PCR, data were processed based on four to ﬁve mice in
each group. The data for characterization of the extracts were presented
as mean ± SD for three replicates. The effects of phenolic compounds
from cambuci at two doses on the studied parameters were analyzed
using a one-way (treatment) analysis of variance (ANOVA). Signiﬁcant
effects were analyzed using Tukey's studentized range or post hoc
Fisher's least signiﬁcant difference (LSD) test (statistical signiﬁcance
was determined at p b 0.05). The statistical analysis was performed
using the SAS 9.3 package (SAS Institute, Inc., Cary, NC).3. Results
Figs. 1a and 1b show a representative chromatographic proﬁle
(270 nm) of phenolic compounds extracted from cambuci. Flavonoid
glycosides and phenolic acids were themost widespread phenolic com-
pounds detected by HPLC analysis of the CBC extract. Quercetin deriva-
tives and ellagic acid were detected in the methanolic fraction, while in
themethanol/ammonia fraction only ellagic acid was detected predom-
inantly. The characterization of the phenolic-rich extracts from cambuci
in relation to total phenolic, proanthocyanidin, ﬂavonoid, and phenolic
acid contents, and antioxidant capacity is presented in Table 2. As can
be seen, tanninswere themain phenolic compounds in cambuci extract.
Roughly, proanthocyanidins and ellagitannins (calculated discounting
free ellagic acid from the total ellagic acid content) corresponded
together to more than 80–85% of the total polyphenols. The concentra-
tions of total phenolic compounds found (2.26mg GAE/mL and 4.01mg
GAE/mL, for CBC18 and CBC32 respectively) were used to calculate the
mean daily dose administered to eachmice per day (18mgGAE/kg/day
and 32 mg GAE/kg/day for CBC18 and CBC32, respectively, considering
the body weight of each mice as 25 g at the beginning of the experi-
ment). The in vitro antioxidant capacity was proportional to the pheno-
lic concentrations; and the extract showed low inhibitory activity
toward pancreatic lipase in vitro (IC50 321 μg GAE/mL reaction) when
compared to control Orlistat (IC50 28.3 μg GAE/mL reaction).
As expected, the groups fed on the HFHS diet developed marked
obesitywhen comparedwithmice kept on a chowdiet. The administra-
tion of CBC in both doses did not produce statistical difference in the
body weight relative to the HFHS group (Fig. 2a). However, the total
weight gain in the HFHS group tended to be slightly larger than that of
the CBC groups (8.4 ± 0.7 for HFHS vs. 7.6 ± 1.1 and 7.1 ± 0.6 for
CBC18 and CBC32, respectively) but overall this difference was not
signiﬁcant (Fig. 2b). The intake of a high-fat, high-sucrose diet induced
an increase (p b 0.05) in weight gain when compared to the animals
receiving chow diet.n the methanol (a) and methanol:ammonia (b) fractions from cambuci fruit.
Table 2
Characterization of phenolic-rich extracts of cambuci, CBC18 and CBC32, administered to





Total phenolics (mg GAE/mL) 2.26 ± 0.15 4.01 ± 0.25
Proanthocyanidins (mg QTE/mL) 0.51 ± 0.04 1.04 ± 0.05
Flavonoids and phenolic acids (μg/mL)
Quercetin derivatives 3.53 ± 0.40 6.44 ± 0.70
Free ellagic acid 9.57 ± 0.29 16.98 ± 0.52
Total ellagic acid 1312 ± 15 2400 ± 52
ORAC (μmol Trolox/mL) 12.91 ± 0.77 20.20 ± 1.83
DPPH (μmol Trolox/mL) 14.71 ± 1.78 29.44 ± 1.52
FRAP (μmol Trolox/mL) 13.87 ± 2.07 24.28 ± 3.73
Pancreatic lipase inhibition
(IC50 — μg GAE/mL)a
n.d 321.91 ± 15.06
Results are expressed as mean ± SD values (n = 3); GAE, gallic acid equivalent; QTE,
quebracho tannin equivalent; n.d., not detected.
a Orlistat control IC50 28.3 μg/mL reaction.
Table 3
Diet consumption and organ weights of mice fed on high-fat high-sucrose or chow diets
and receiving water (Chow and HFHS groups) or phenolic-rich extracts from cambuci at
two doses (CBC18 and CBC32) by gavage for 8 weeks.
Chow HFHS CBC18 CBC32
Intake
Food intake (g/day) 3.89 ± 0.06a 3.07 ± 0.04b 2.90 ± 0.06bc 2.81 ± 0.06c
Energy intake
(kJ/day)
48.56 ± 0.77c 59.59 ± 0.83a 56.33 ± 1.13ab 54.48 ± 1.20b
Food efﬁciency † 2.21 ± 0.32b 9.43 ± 0.81a 8.99 ± 0.81a 8.77 ± 0.78a
Tissue weight (mg)
Liver 1013 ± 31a 1056 ± 47a 983 ± 41a 962 ± 44a
Heart 119 ± 3a 119 ± 7a 109 ± 3a 110 ± 3a
Gastrocnemius
muscle
140 ± 4a 153 ± 4a 147 ± 6a 144 ± 4a
Retroperitoneal A. T. 80 ± 14b 464 ± 36a 498 ± 81a 479 ± 53a
Epididymal A. T. 287 ± 22b 1177 ± 108a 1197 ± 180a 1122 ± 99a
Inguinal A. T. 192 ± 24b 870 ± 79a 858 ± 161a 880 ± 103a
Brown A. T. 56 ± 6b 109 ± 17a 101 ± 11a 87 ± 12ab
Results are expressed as mean ± SEM values (n= 9–10 per group).
a–cMeans within a row marked with different letters are signiﬁcantly different (p b 0.05).
A. T., adipose tissue.
† Expressed as (body weight gain [in g] / food intake [in g]) × 100.
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12.5 kJ/g, HFHS vs. Chow), the groups fed on a HFHS diet, receiving the
phenolic-rich extract or not, consumed more calories than the Chow
group (Table 3). The higher dose of phenolic-rich extract from cambuci
(CBC32) diminished (p b 0.05) the food and energy intake when
compared to the HFHS group. Food efﬁciency was similar between
the groups fed on the HFHS diet, suggesting a similar behavior in the
efﬁciency to convert dietary energy into body mass; and the HFHS,
CBC18, and CBC32 groups showed higher food efﬁciency when com-
pared to the Chow group.
When the fasting blood glucose during the experiment was com-
pared, a trend toward an increase was observed for mice receiving
the HFHS diet. However, despite of the elevation in blood glucose,
mice receiving CBC presented lower average values than the HFHS
group (Fig. 3). Fasting blood glucose in the CBC32 group, but not
in the CBC18 group, signiﬁcantly decreased (p b 0.05) at 4, 5, and
8 weeks of the experiment when compared to the HFHS group, which
showed an accelerated increase in the blood glucose during the experi-
mental period. In addition, no signiﬁcant differences (p N 0.05) in blood
glucose levels were observed among the CBC32 and Chow groups at
weeks 4, 5, 6, and 8.
To further study the effect of phenolic compounds from cambuci on
glucose metabolism, a glucose tolerance test (GTT) was performed.
Blood glucose levels were consistently higher (p b 0.05) during the
GTT in the HFHS group when compared to levels in both CBC18 and
CBC32 groups (Fig. 4a). Phenolic compounds from cambuci, especially
CBC32, improved glucose intolerance linked to HFHS intake by the
reduction (p b 0.05) of both the blood glucose concentration and the
area under the mean incremental glucose curve. Fasting blood glucose,
measured just before intraperitoneal glucose administration, was not
different among the HFHS-fed groups, receiving the phenolic-richFig. 2.Bodyweight (a) andweight gain (b) ofmice fed on high-fat high-sucrose or chowdiets an
doses (CBC18 and CBC32) by gavage for 8 weeks. Data are means ± SEM from each treatmentextract or not, but higher (p b 0.05) than in the chow-fed mice. How-
ever, blood glucose was signiﬁcantly lower during the GTT in the mice
receiving CBC18 and CBC32 compared to the HFHS group at 15 min
(16.32±0.74 and 14.65±0.58 vs. 18.04±0.69mmol L−1 respectively),
30 min (16.19 ± 0.65 and 13.52 ± 0.46 vs. 18.74 ± 0.76), 45 min
(15.15 ± 0.71 and 13.38 ± 0.64 vs. 16.71 ± 0.51), 60 min (14.73 ±
0.88 and 12.10 ± 0.65 vs. 17.64 ± 0.75), and 90 min (11.90 ± 0.44 and
11.16 ± 0.52 vs. 13.64 ± 0.65 mmol L−1). In the HFHS group, unexpect-
edly, the GTT was accompanied by a reduction in the plasma insulin
concentration at 30min (Fig. 4b). However, the area under the mean in-
cremental insulin curve remained higher, but not signiﬁcantly different,
compared to both the CBC18 and CBC32 groups, where a reduced con-
centration of insulin was observed.
The diet and/or administration of CBC did not have a signiﬁcant
effect on the tissue weight of mice, including liver, heart and gastrocne-
mius muscle (Table 3). In agreement with the fact that no differences
were detected in body weight, adipose tissue masses were also not
signiﬁcantly different in both the CBC18 and CBC32 groups when com-
pared to the HFHS group. The two doses of phenolics did not protect
against the HFHS diet-induced fat accumulation, as shown by the
weight of retroperitoneal, epididymal, inguinal, and brown adipose
tissues (BAT). As expected, fat accumulation was lower (p b 0.05) in
the Chow group when compared to the groups fed the HFHS diet
(Table 3). However, no differences were observed in BAT weight in
the CBC32 group when compared to the Chow group.
Plasma lipid level abnormalities may be related to the pathogenesis
of obesity-related diseases. There were signiﬁcant differences in plasma
lipid levels among the groups fed on the HFHS diet, receiving phenolic-d receivingwater (Chow andHFHS groups) or phenolic-rich extracts from cambuci at two
(n= 9–10). *(p b 0.05) Chow vs. other groups; †(p b 0.05) CBC32 vs. HFHS.
Fig. 3.Weekly variation of fasting blood glucose (6 h) inmice fed on high-fat high-sucrose
or chowdiets and receivingwater (ChowandHFHS groups) or phenolic-rich extracts from
cambuci at two doses (CBC18 and CBC32) by gavage for 8 weeks. Data are mean ± SEM
from each treatment (n = 9–10). ‡(p b 0.05) HFHS vs. CBC32 and Chow; †(p N 0.05)
Chow= CBC32.
Fig. 4. Blood glucose (a) and the glucose area-under-the-curve (AUC; inset) and plasma
insulin (b) and the insulin AUC (inset) during the glucose tolerance test in mice fed on
high-fat high-sucrose or chow diets and receiving water (Chow and HFHS groups) or
phenolic-rich extracts from cambuci at two doses (CBC18 and CBC32) by gavage for 8
weeks. Data are mean ± SEM from each treatment (n = 9–10 for blood glucose; n =
4–5 for plasma insulin). a–cBarswith different letterswere signiﬁcantlydifferent (p b 0.05).
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HDL cholesterol levels was observed in the CBC32 group, and a non-
signiﬁcant increase of 9.6% was observed in the CBC18 group when
compared to HFHS group. The values for LDL cholesterol were lower
(p b 0.05) for CBC32 when compared to HFHS. LDL cholesterol levels
in both CBC18 and CBC32 were similar (p N 0.05) to those animals in
the Chow group. Furthermore, although no differences were observed
in total cholesterol and triacylglycerol levels, the means were 7.7 and
13.1% lower, respectively, in the CBC32 group when compared to the
HFHS group.
To further explore the mechanism underlying obesity induced by the
HFHS diet and its amelioration byphenolic compounds fromcambuci, the
effects of these compounds on inﬂammation markers in adipose tissue
were evaluated. The diet-induced pro-inﬂammatory response induced
by HFHS feeding in retroperitoneal adipose tissue was attenuated after
administration of phenolic compounds from cambuci. This attenuation
was signiﬁcant for both the CBC18 and CBC32 groups as evaluated by
the reduced mRNA levels of pro-inﬂammatory cytokine tumor necrosis
factor-alpha (TNF-α) and interleukin-6 (IL-6) (p b 0.05) when compared
to HFHS group (Figs. 6a and 6b). Because obesity is known to promote
the recruitment and inﬁltration of leukocytes into adipose tissue, the ex-
pression of macrophage markers in retroperitoneal adipose tissue was
also evaluated. As expected, HFHS feeding increased adipose tissue
mRNA levels ofmacrophagemarkers CD11b, F4/80, and CD86. Interesting-
ly, despite the absence of differences in the adiposity and weight gain,
administration of phenolic compounds from cambuci signiﬁcantly atten-
uated the HFHS-induced increase inmRNA levels ofmacrophagemarkers
CD11b and F4/80 in adipose tissue (Figs. 6c and 6d). Phenolic compounds
from cambuci at both doses signiﬁcantly attenuated the increased
(p b 0.05) mRNA levels of CD11b induced by HFHS, whereas only mice
treated with the higher cambuci dose (CBC32) displayed a signiﬁcant
reduction in F4/80 mRNA levels in comparison to the HFHS fed mice.
Similarly, administration of phenolics was also linked to a signiﬁcant
reduction (p b 0.05 for CBC18, and p b 0.01 for CBC32 when compared
to HFHS group) in the expression of classically activated macrophages
(pro-inﬂammatory M1) marker CD86 (Fig. 6e).
4. Discussion
This study demonstrated that phenolic compounds from cambuci
have a protective role against the disarrangements in glucosehomeostasis and adipose tissue inﬂammation induced by intake of
the HFHS diet. More speciﬁcally, phenolic compounds from cambuci
improved glucose tolerance, reduced fasting glycemia and insulinemia,
protected against dyslipidemia, and attenuated adipose tissue macro-
phage recruitment and expression of inﬂammatory markers. Our ﬁnd-
ings add phenolic compounds from cambuci to an extensive list of
fruits such as berries and apples and their constituents, that were previ-
ously shown to protect against insulin resistance, hyperglycemia, and
dyslipidemia associated with obesity and type 2 diabetes (Del Rio,
Borges, & Crozier, 2010; Manzano & Williamson, 2010).
Phenolic compounds from cambuci were tested at two different
doses, with the lowest corresponding to 18 mg gallic acid equivalent
(GAE)/kg body weight, which is equivalent to consuming the quantity
of phenolic compounds present in a minimum of 0.5 g cambuci dry
weight/kg body weight. This dose, in turn, is equivalent to consuming
400 g of fruit (with approximately 90% moisture content) per day by a
70-kg individual. This is the portion of fruits recommended by WHO/
FAO for the prevention of chronic diseases such as heart disease, cancer,
diabetes, and obesity (WHO/FAO, 2004). The major classes of phenolic
compounds found in cambuci are proanthocyanidins and ellagic acid
derivatives such as ellagitannins (hydrolyzable tannins, about 58-60%
of total phenolics), followed in the lowest proportion by ﬂavonoids,
mainly quercetin derivatives (Abe, Lajolo, & Genovese, 2012;
Fig. 5. Plasma lipid levels ofmice fed on high-fat high-sucrose or chowdiets and receivingwater (Chow andHFHS groups) or phenolic-rich extracts from cambuci at two doses (CBC18 and
CBC32) by gavage for 8 weeks. Data are mean ± SEM from each treatment (n= 9–10). *(p b 0.05) vs. other groups; &(p N 0.05) vs. Chow; #(p b 0.05) vs. HFHS.
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proanthocyanidin content (condensed tannins) represent about 22–25%
of total phenolics (Table 2). The predominance of tannins (hydrolysable
or condensed) is probably associated with cambuci fruit features such
as astringency and extremely sour taste. Previous studies have reported
that ellagitannins and ellagic acid, which also are found in fruits such as
berries and pomegranate, have several beneﬁcial actions for human
health, protecting it from the development of cardiovascular disease
and reducing the risk of metabolic complications (Del Rio et al., 2010).
In agreement with this notion, our major ﬁndings indicated that
phenolic compounds from cambuci attenuated glucose intolerance,
hyperinsulinemia (slightly low) and hyperglycemia induced by the
intake of the HFHS diet. These results can be partly attributed to an im-
provement in peripheral insulin response, supporting the hypothesis
that the phenolic compounds from fruits play an important part in the
protection from the disarrangements in glucose homeostasis associated
with obesity, diabetes, and metabolic syndrome (Cherniack, 2011). The
glucose-lowering properties of phenolics from cambuci may be associ-
ated with various putativemechanisms bywhich glycemia can be regu-
lated, involvingmultiple pathways. In addition to the inhibitory activity
of carbohydrate-hydrolyzing enzymes (α-amylase and α-glucosidase),
previously demonstrated in in vitro enzymatic assays (Gonçalves et al.,
2010) for cambuci, phenolic compounds in fruits have also been shown
to inhibit intestinal glucose transport, inhibiting sodium-dependent glu-
cose transporter 1 (SGLT1) and glucose transporter 2 (GLUT2) (Ader,
Block, Pietzsch, & Wolffram, 2001; Manzano & Williamson, 2010).
Furthermore, in contrast to the intestinal GLUT2, a previous study
demonstrated that tannins, a major component of phenolics found in
cambuci, induce glucose transporter 4 (GLUT4) expression through acti-
vation of an insulin-mediated signaling pathway in adipocytes (Liu et al.,
2005).
As glucose uptake by skeletal muscle accounts for the majority of
glucose disposal in the post-prandial period, CBC phenolics could also
have an effect on key regulatory proteins involved in glucose uptake
into muscle (GLUT4, AKT, ERK, and others).Other mechanism explaining lower hyperglycemia may be the
suppression of hepatic glucose production through the inhibition of en-
zymes involved in glycogenolysis and/or gluconeogenesis. Phenolic
compounds present in persimmon (Diospyros kaki) leaf and cinnamon,
including proanthocyanidins and ﬂavonoids (also present in cambuci),
were effective in decreasing glucose-6-phosphatase (G6Pase) and phos-
phoenolpyruvate carboxykinase (PEPCK) activities in the liver of type 2
diabetic mice and H4IIE rat hepatoma cells (Cheng et al., 2012; Jung,
Park, Kim, & Choi, 2012).
There were no statistical differences between the groups in regards
to the plasma insulin concentration during the GTT, possibly because
of the modest number covered in the data analysis (4–5). However, it
is possible to observe that the insulin secretion at 30 min during GTT
was lower, but not signiﬁcantly, in the HFHS group even though their
blood glucose level was higher when compared with the CBC and
Chow groups (Fig. 4). The glucose intolerance in this group may be
caused by the regulation of insulin secretion from the pancreas through
higher levels of circulating free fatty acids and leptin, which promote the
suppression of second-phase insulin secretion (Sumiyoshi, Sakanaka, &
Kimura, 2006). This reduction in early insulin secretion from pancreatic
islets was observed in C57BL/6J mice fed a high-sucrose diet (Sumiyoshi
et al., 2006). Our ﬁndings suggest that the administration of phenolic
compounds from cambuci may result in protection against β cell failure
induced by nutrient toxicity (glucolipotoxicity) (Biden, Boslem, Chu, &
Sue, 2014), and this phenomenon may be attributed to alternative path-
ways, including their role in reducing oxidative stress.
In the present study, we found that phenolic compounds from
cambuci did not affect the body weight and adiposity in mice fed the
HFHS diet. Previously, Lu, Zhu, Shen, and Gao (2012) reported that
administration of phenolic compounds from green tea (rich in epigallo-
catechin gallate) to rats fed with a high-fat diet was associated with a
reduction in body weight. In contrast, Neyrinck et al. (2013) showed
that phenolic-rich extract from pomegranate peel, which include the
predominant ellagitannins (similar to cambuci), did not modify the
high-fat-induced body weight gain and adiposity in Balb/c mice. These
Fig. 6. Retroperitoneal adipose tissue mRNA expression of TNF-α (a), IL-6 (b), CD11b (c), F4/80 (d), and CD86 (e) in mice fed on high-fat and high-sucrose and chow diets and receiving
phenolic-rich extracts from cambuci at two doses (CBC18 and CBC32) by gavage for 8 weeks. Data are mean ± SEM from each treatment (n= 5). *p b 0.05 vs. HFHS.
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diversity of phenolics used in the different studies, methods of adminis-
tration, but also from various genetic backgrounds of animals, aswell as
diverse diets. Likewise, our observations also indicated that the CBC
phenolics did not affect tissue weight including adipose tissues (retro-
peritoneal, epididymal, inguinal and brown), heart, liver, and gastrocne-
miusmusclewhen compared to theHFHS group. In accordancewith our
results, a previous study reported that phenolics fromberries, which are
characterized by thepresence of ellagitannins and anthocyanins, did not
signiﬁcantly alter tissue weight, such as liver, heart, epididymal, and
subcutaneous adipose tissues in mice fed an obesogenic high-fat diet
(Prior et al., 2009). The lower food and energy intake in the animals
receiving CBC32 may be attributed to various endocrine parameters
that regulate food intake. Phenolics may interact speciﬁcally with vari-
ous appetite control pathways and reduce food intake, including leptin
or leptin receptor, peripheral factors, and neuropeptides (Kao, Hiipakka,
& Liao, 2000).
Our results indicated that administration of phenolic compounds
from cambuci at a dosage of 32 mg GAE/kg body weight for 8 weeks
increased the HDL-cholesterol and decreased the LDL-cholesterol con-
centrations in plasma in the animals fed on a high-fat, high-sucrose
diet. Dyslipidemia in obesity is characterized by increased levels
of LDL-cholesterol, triacylglycerols, and total cholesterol, and lower
HDL-cholesterol levels. These lipoproteins, mainly HDL and LDL-cholesterols, are predictors of cardiovascular disease risk (Van Gaal,
Mertens, & De Block, 2006), and the HDL and LDL-cholesterol ratio is a
major risk factor for coronary heart disease. The increase in plasma
HDL-cholesterol level observed in CBC groups may facilitate the trans-
port of cholesterol from peripheral tissues to the liver for its catabolism
(Prince & Sathya, 2010). High HDL-cholesterol concentration may pro-
mote the efﬂux of cholesterol from macrophages in the endothelium,
inhibit the oxidative modiﬁcation of LDL cholesterol, vascular inﬂam-
mation and thrombosis, promote endothelial repair, enhance endothe-
lial function, and improve diabetic control (Rye & Barter, 2014). The
mechanisms by which phenolic compounds elevate HDL-cholesterol
concentrations remain unclear. One hypothesis is that up-regulation of
lecithin cholesterol acyl transferase by treatment with phenolics may
stimulate HDL-cholesterol turnover (Prince & Sathya, 2010). On the
other hand, evidence suggests that phenolics may increase the expres-
sion and production of apolipoprotein A1, themajor protein component
of HDL-cholesterol, in a human hepatoma cell line HepG2 (Lamon-Fava,
2000). Recently, Di Donna et al. (2014) reported that phenolic com-
pounds isolated from bergamot (Citrus bergamia) fruit were effective
in the treatment of hypercholesterolemia in a rat model. The daily
supplementation with the phenolic-rich extract reduced the LDL-
cholesterol levels, whereas an increase of the HDL-cholesterol was
observed. These authors also suggested that phenolic compounds can
exert inhibitory effects on 3-hydroxy-3-methylglutaryl-CoA reductase
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latter process allows a subsequent clearance of LDL-cholesterol from
systemic circulation. In the present study, we also found that adminis-
tration of CBC phenolics had no effect on total cholesterol and triacyl-
glycerol levels. Although values tended to be lower (CBC32 group)
compared with the HFHS group, no signiﬁcant changes were observed.
Unchanged total cholesterol levelsmay be the result of the reduced LDL-
cholesterol and increased HDL-cholesterol concentrations. Evidence-
based studies show an association between consumption of polyphe-
nols and reduced plasma triacylglycerol levels, which may explain, at
least in part, the reduced cardiovascular mortality associated with the
consumption of diets rich in fruit and vegetables. Here, however, triac-
ylglycerols were unaltered. Similar to our results, the chronic adminis-
tration of pomegranate juice to type 2 diabetic subjects did not alter
total triacylglycerol or cholesterol levels but increased HDL-cholesterol
(Rosenblat, Hayek, & Aviram, 2006).
Relative gene expression in the retroperitoneal adipose tissue for in-
ﬂammatory cytokines and macrophage-speciﬁc markers showed that
the administration of phenolic compounds from cambuci decreased
inﬂammatory response in the adipose tissue through inhibition of
gene expression of TNF-α, IL-6, CD11b, F4/80, and CD86. Considering
the data presented herein, it is reasonable to hypothesize that the
lower inﬂammatory mediator expressions by CBC phenolics might
act in the adipose tissue or other tissues that participate in insulin-
stimulated glucose uptake (e.g., skeletal muscle). As it is known, obesity
is associated with increased production of pro-inﬂammatory cytokines,
such as TNF-α and IL-6, in adipose tissue. These cytokines activate
several serine kinases, including IκB kinase (IKK) and JNK, which are
capable of inhibiting insulin action by promoting the phosphorylation
of serine residues of the insulin signaling pathway, including serine
phosphorylation of insulin receptor substrate-1 (IRS-1) (McArdle,
Finucane, Connaughton, McMorrow, & Roche, 2013). Favoring our
hypothesis and conﬁrming previous ﬁndings, both TNF-α and IL-6
expression levels have been reduced in white adipose tissue and de-
scribed to mediate the anti-inﬂammatory properties of other phenolic
compounds such as epigallocatechin gallate in rats receiving a high-fat
diet (Bao et al., 2014), or rice bran extracts (rich in polyphenols)
(Candiracci, Justo, Castano, Rodriguez-Rodriguez, & Herrera, 2014). An-
other mechanism by which phenolic compounds may reduce TNF-α is
by suppressing the activity of the proinﬂammatory transcriptional fac-
tor NFκB. Park et al. (2012) showed that green tea extract (rich in epi-
gallocatechin gallate) lowers IκB phosphorylation in the epididymal
adipose tissue of obese rats. The activation of NFκB in the cytosol is reg-
ulated by phosphorylation and proteolysis of IκB. Degradation of IκB al-
lows nuclear translocation of NFκB, and thus, NFκB binds to promote
sites for gene transcription. As NFκB regulates TNF-α expression, the
suppression of NFκB may reduce TNF-α expression (Park et al., 2012).
Furthermore, a previous study showed that quercetin decreased TNF-
α-induced IL-6, IL-1b, and IL-8 gene expression, in cultures of human ad-
ipocytes. Potential mechanisms for these anti-inﬂammatory actions in-
clude direct effects such as suppression of the activation of ERK, JNK, and
NFκB, and indirect effects via PPARγ activation (Chuang et al., 2010). CBC
phenolics decreased the accumulation of macrophages and M1 macro-
phages into adipose tissue.Macrophage accumulation in the adipose tis-
sue occurs in the context of continuous tissue remodeling that is
pathologically accelerated in the obese state. This accumulation is close-
ly related to the dysfunction of glucose and lipid metabolism (Patel,
Buras, & Balasubramanyam, 2013; Xiao et al., 2014). With excessive
weight gain, extreme increases in adipocyte size are accompanied by
an elevated frequency of adipocyte death and macrophage accumula-
tion and their M1 polarization (Patel et al., 2013). In agreement with
previous ﬁndings, phenolic compounds also signiﬁcantly decreased
macrophage inﬁltration in adipose tissues of rats fed a high-fat diet
(Bao et al., 2014).
Here, we demonstrated that the administration of CBC reduces adi-
pose inﬂammation by decreasing macrophage inﬁltration, polarizationtoM1proinﬂammatory phenotype and cytokine secretion. These effects
might alleviate insulin resistance in obesity, as proinﬂammatory cyto-
kines are strong inhibitors of insulin action in adipocytes, myocytes
and hepatocytes.
5. Conclusion
In summary, phenolic compounds from cambuci fruit have an im-
portant role in counteracting the metabolic complications associated
with obesity. Our results indicated that phenolic compounds from
cambuci were effective in ameliorating glucose tolerance, as well as
reducing insulinemia and fasting glycemia, and improving dyslipidemia
by increasing HDL-cholesterol and decreasing the LDL-cholesterol.
Although no changes in body weight gain and adiposity were observed
after administration of CBC, an attenuation of adipose tissue inﬂam-
mation as evidenced by the reduction in pro-inﬂammatory cytokines
TNF-α and IL-6 and macrophage recruitment were observed in the
retroperitoneal adipose tissue for both doses tested. Further studies
are under way to determine additional molecular mechanisms in-
volved in the effects observed. Thus, phenolic compounds may be
an adjuvant therapeutic potential for improving obesity manage-
ment and its complications.
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